Skip to content

Progyny PGNY Price / book

Price / book at other companies

CVS Health logo
CVS HealthCVS
1.2×+0.1×
UnitedHealth Group logo
UnitedHealth GroupUNH
2.4×-2.4×
Natera, Inc. logo
Natera, Inc.NTRA
16×+0.6×
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
+0.4×
Organon logo
OrganonOGN
1.7×-5.4×
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
7.2×

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.09B-27.1%
Enterprise value$1.98B-29.6%
P/E30.8×-23.7×
P/S1.6×-0.7×

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Calculated from Progyny’s reported figures.

Based on the most recent quarter.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's price / book?
Progyny (PGNY) reported price / book of 3.2× in Q1 2026.
How has Progyny's price / book changed year-over-year?
Progyny's price / book decreased by 22.5% year-over-year, from 4.1× to 3.2×.
What is the long-term trend for Progyny's price / book?
Over 5 years (2020 to 2025), Progyny's price / book has grown at a -28.5% compound annual growth rate (CAGR), from 23× to 4.3×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.